jueves, 21 de noviembre de 2019

CAR-T therapies should be made by academic medical centers - STAT

CAR-T therapies should be made by academic medical centers - STAT

Daily Recap

Opinion: Letting academic medical centers make CAR-T drugs would save billions

By DAVID MITCHELL AND SAAD KENDERIAN AND S. VINCENT RAJKUMAR


GERARD JULIEN/AFP VIA GETTY IMAGES
CAR-T drugs for treating blood cancers could be made faster in academic medical centers, instead of by pharma companies, and save billions of dollars.

No hay comentarios: